No Woman Left Behind | Circulation: Heart Failure
See Article by Vallabhajosyula et al For many clinicians, the acute myocardial infarction (AMI) presentation invokes classic imagery of an
Read moreSee Article by Vallabhajosyula et al For many clinicians, the acute myocardial infarction (AMI) presentation invokes classic imagery of an
Read moreWhat is New? Younger women with acute myocardial infarction-cardiogenic shock received less frequent coronary angiography (78.3% versus 81.4%), early coronary
Read moreWhat is New? In this retrospective multicenter study, we observed that patients who participated in cardiac rehabilitation (CR) have a
Read moreCirculation: Heart Failure, <a href=”https://www.ahajournals.org/toc/circheartfailure/13/10″>Volume 13, Issue 10</a>, Page e007393, October 1, 2020. Source link
Read moreCirculation: Heart Failure, <a href=”https://www.ahajournals.org/toc/circheartfailure/13/10″>Volume 13, Issue 10</a>, Page e007647, October 1, 2020. Source link
Read more[*][**][***] What is New? We identified genomic regulatory regions used in the human left ventricle from normal and failed hearts
Read moreBackground: Among patients with heart failure and reduced ejection fraction (HFrEF, left ventricular [LV] EF ≤40%) sacubitril/valsartan (S/V) treatment is
Read moreCirculation: Heart Failure, Ahead of Print. Source link
Read moreHaving the right technology to provide clarity and accurate insights to patient health is very significant in this time of
Read moreBackground: Beta-blockers (BB) are mainstay therapy for heart failure with reduced ejection fraction (HFrEF). However, individual patient responses to BB
Read more